Safe Orthopaedics SA (EPA:ALSAF)
France flag France · Delayed Price · Currency is EUR
0.6400
0.00 (0.00%)
Jun 30, 2026, 5:18 PM CET

Safe Orthopaedics Statistics

Total Valuation

EPA:ALSAF has a market cap or net worth of EUR 127,514. The enterprise value is 13.24 million.

Market Cap127,514
Enterprise Value 13.24M

Important Dates

The next estimated earnings date is Friday, October 9, 2026.

Earnings Date Oct 9, 2026
Ex-Dividend Date n/a

Share Statistics

EPA:ALSAF has 199,241 shares outstanding.

Current Share Class 199,241
Shares Outstanding 199,241
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.02
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.47
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio 0.41
Quick Ratio 0.24
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -6.69
Interest Coverage -5.58

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -23.72%
Return on Invested Capital (ROIC) -87.57%
Return on Capital Employed (ROCE) 32.31%
Weighted Average Cost of Capital (WACC) 2.96%
Revenue Per Employee 61,655
Profits Per Employee -53,724
Employee Count87
Asset Turnover 0.47
Inventory Turnover 0.57

Taxes

Income Tax -31,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.33% in the last 52 weeks. The beta is -0.86, so EPA:ALSAF's price volatility has been lower than the market average.

Beta (5Y) -0.86
52-Week Price Change -73.33%
50-Day Moving Average 0.62
200-Day Moving Average 1.10
Relative Strength Index (RSI) 50.97
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, EPA:ALSAF had revenue of EUR 5.36 million and -4.67 million in losses. Loss per share was -23.46.

Revenue5.36M
Gross Profit 3.55M
Operating Income -4.34M
Pretax Income -4.71M
Net Income -4.67M
EBITDA -1.37M
EBIT -2.86M
Loss Per Share -23.46
Full Income Statement

Balance Sheet

The company has 390,000 in cash and 13.50 million in debt, with a net cash position of -13.11 million or -65.81 per share.

Cash & Cash Equivalents 390,000
Total Debt 13.50M
Net Cash -13.11M
Net Cash Per Share -65.81
Equity (Book Value) -10.68M
Book Value Per Share -53.60
Working Capital -12.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.01 million and capital expenditures -4,000, giving a free cash flow of -2.02 million.

Operating Cash Flow -2.01M
Capital Expenditures -4,000
Depreciation & Amortization 513,000
Net Borrowing 3.15M
Free Cash Flow -2.02M
FCF Per Share -10.12
Full Cash Flow Statement

Margins

Gross margin is 66.24%, with operating and profit margins of -80.82% and -87.14%.

Gross Margin 66.24%
Operating Margin -80.82%
Pretax Margin -87.71%
Profit Margin -87.14%
EBITDA Margin -25.62%
EBIT Margin -53.23%
FCF Margin n/a

Dividends & Yields

EPA:ALSAF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -3,665.48%
FCF Yield -1,581.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 0.001.

Last Split Date Jul 7, 2025
Split Type Reverse
Split Ratio 0.001

Scores

EPA:ALSAF has an Altman Z-Score of -2.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.55
Piotroski F-Score 2